A novel polyrotaxane-based delivery system for scutellarin: preparation, characterization, and in vitro evaluation

- The scutellarin-polyrotaxane (SCU-PR) was prepared and characterized.
- The SCU-PR had higher antiproliferative activities than free SCU and SCU-Conjugate.
- The SCU-PR is potentially useful for its application on human colon cancer chemotherapies.